Axcella Health Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Axcella Health Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q2 2023.
  • Axcella Health Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $428K, a 27.9% decline year-over-year.
  • Axcella Health Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $2.45M, a 53.3% decline year-over-year.
  • Axcella Health Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.58M, a 42.6% decline from 2021.
  • Axcella Health Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.24M, a 0.7% decline from 2020.
  • Axcella Health Inc. annual Share-based Payment Arrangement, Expense for 2020 was $6.29M, a 7.95% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2.45M $428K -$166K -27.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.61M $539K -$970K -64.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.58M $530K -$941K -64% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $4.52M $950K -$717K -43% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $5.24M $594K -$1.08M -64.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $6.32M $1.51M +$81K +5.67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.24M $1.47M +$111K +8.16% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $6.13M $1.67M +$295K +21.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $5.84M $1.68M -$279K -14.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $6.12M $1.43M -$171K -10.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $6.29M $1.36M -$145K -9.64% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $6.43M $1.37M -$306K -18.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $6.74M $1.96M +$452K +30.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $6.29M $1.6M +$462K +40.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $5.82M $1.51M +$624K +70.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 $5.2M $1.68M +$856K +104% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $4.34M $1.5M +$797K +113% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $3.55M $1.14M +$769K +209% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $2.78M $881K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 $822K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $707K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $368K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.